Best TouchPODCAST Podcasts (2026)

1
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC 1:35:56

Play Pause

14h ago1:35:56

1:35:56

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resi…

1
Managing cytopenias: The path to transfusion independence for patients with myelofibrosis 36:46

1M ago36:46

36:46

touchIN CONVERSATION for touchHAEMATOLOGY The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with J…

1
Innovations and advances in CML: Focus on navigating early-line options and maintaining quality of life 38:34

2M ago38:34

38:34

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short interviews with three leading experts who provide their insights into early-line management of chronic myeloid leukaemia and the impact on quality of life. The experts: Dr Delphine Rea, Hôpital Saint-Louis, Paris, France Prof. Andreas Hochhaus, Jena University Hosp…

1
Breakthroughs in treating NSCLC: Targeting KRAS 31:11

2M ago31:11

31:11

touchTALKS for touchONCOLOGY Listen to Dr Christine Bestvina, as she evaluates the latest data on KRAS mutations in NSCLC and explores how emerging evidence for targeted therapies could influence clinical decision-making. The expert Dr Christine Bestvina, University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside of the UK. This …

1
HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers 45:43

2M ago45:43

45:43

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with four leading experts as they discuss the role of HER2 as a targetable biomarker in BTC and GEA. They examine the present treatment landscape for HER2-positive BTC and GEA and evaluate clinical implications of recent approvals and advances in current and emerging HER2-ta…

1
Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT 49:06

2M ago49:06

49:06

touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY Listen to a panel of leading experts discuss the optimal management of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), with a focus on peptide receptor radionuclide therapy (PRRT). The faculty provide their insights on the current state of the art, the evolving role of PRRT in…

1
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC 1:06:08

2M ago1:06:08

1:06:08

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resi…

1
Eyeing better outcomes in diabetic macular oedema: Clinical insights on the evolving role of corticosteroids 34:18

2M ago34:18

34:18

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with two medical retina specialists and a biomarker expert who will provide their insights into the pathophysiology of diabetic macular oedema (DMO), including the inflammatory mechanisms of disease and how they may impact treatment. The faculty will also consider the clinica…

1
Diagnosis and treatment of patients with Lennox–Gastaut syndrome 56:25

2M ago56:25

56:25

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of experts in epilepsy as they discuss how to promptly and accurately diagnose and manage Lennox–Gastaut syndrome (LGS). Moderated by a leading European expert, this episode brings together faculty from the Gulf region and Japan, as they explore diagnostic approaches in their regions, befor…

1
Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies 32:10

3M ago32:10

32:10

touchEXPERT FOCUS for touchCARDIO Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic classes that aim to address the unmet needs of patients with hypertrophic cardiomyopathy. The faculty will review current therapeutic approaches for managing obstructive versus nonobstructive hypertrophi…

1
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC 30:17

3M ago30:17

30:17

Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resi…

1
Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages 32:13

3M ago32:13

32:13

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC. The expert: Prof. Jean-Pascal Machiels, Cliniques unive…

1
FCS unmasked: Closing gaps in diagnosis, treatment and patient support 35:25

3M ago35:25

35:25

touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY Listen to two experts as they discuss the diagnosis, treatment and how to support patients with FCS. They cover how to recognize key clinical signs and symptoms, strategies to help manage symptoms, reduce triglyceride levels and prevent complications. They also share key insights from …

1
Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics 38:43

3M ago38:43

38:43

touchEXPERT FOCUS for touchHAEMATOLOGY Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and burden of the condition, reviews current and emerging treatments and offers guidance on comprehensive lifespan care that addresses complications, quality of life, and disparities, while highlighting the…

1
Bridging diagnostic and therapeutic gaps in Fabry disease management 39:26

3M ago39:26

39:26

touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment base…

1
Applying patient and disease characteristics to guide R/M NPC treatment 35:45

3M ago35:45

35:45

touchCASES for touchONCOLOGY Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment…

1
Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies? 37:39

4M ago37:39

37:39

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for i…

1
Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes 41:04

4M ago41:04

41:04

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice. The experts: …

1
Stargardt disease: Improving awareness, diagnosis and patient support 37:53

4M ago37:53

37:53

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accuratel…

1
Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies 28:39

4M ago28:39

28:39

touchTALKS for touchENDOCRINOLOGY Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sh…

1
A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making 37:53

5M ago37:53

37:53

touchCASES for touchRESPIRATORY and touchCARDIO This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial d…

1
Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care 28:07

5M ago28:07

28:07

touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including rec…

1
HER2 as a targetable biomarker in gastrointestinal oncology 35:30

5M ago35:30

35:30

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the r…

1
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma 43:31

5M ago43:31

43:31

touchPANEL DISCUSSION for touchONCOLOGY Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecu…

1
Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease 19:06

5M ago19:06

19:06

touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene s…

1
Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025 1:09:32

6M ago1:09:32

1:09:32

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology …

1
Advancing care for patients with infantile haemangiomas: Timing is key 17:14

6M ago17:14

17:14

touchEXPERT FOCUS for touchDERMATOLOGY Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.…

1
Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist 35:34

6M ago35:34

35:34

touchIN CONVERSATION for touchONCOLOGY Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan f…

1
Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease 36:07

7M ago36:07

36:07

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits. The…

1
Applying immunotherapy in clinical practice for patients with early-stage NSCLC 16:33

7M ago16:33

16:33

touchEXPERT FOCUS for touchRESPIRATORY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert P…

1
Towards personalized care for people living with HIV: Supporting open dialogue and informed treatment choices 34:02

7M ago34:02

34:02

NEW touchCASES for touchINFECTIOUS DISEASES Listen to Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation. The experts: Prof. José Arribas, University Hospi…

1
RET-positive NSCLC: Translating insights into targeted approaches 14:36

8M ago14:36

14:36

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical educati…

1
Advances in dry eye disease: From diagnosis to new treatment targets 37:43

8M ago37:43

37:43

touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted ap…

1
Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus 35:33

8M ago35:33

35:33

touchIN CONVERSATION for touchOPHTHALMOLOGY Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monito…

1
The potential of BTKi therapies in delaying MS progression 13:32

8M ago13:32

13:32

touchEXPERT FOCUS for touchNEUROLOGY Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalba…

1
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors 30:27

8M ago30:27

30:27

touchPANEL DISCUSSION for touchNEUROLOGY Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcRn) inhibitors in improving the burden of disease in patients with generalized myasthenia gravis. The faculty will consider how the burden of disease and treatment in patients with generalized myasthen…

1
MDT perspectives on why and how to implement continuous glucose monitoring in T2D 13:26

8M ago13:26

13:26

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Nurse specialist: Ms. Lori Berard Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This ac…

1
MDT perspectives on evolving options for insulin therapy 10:05

8M ago10:05

10:05

Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is…

1
MDT perspectives on understanding clinical inertia in T2D 12:14

8M ago12:14

12:14

Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nor…

1
Navigating the clinical impact of TROP2-targeting in NSCLC 55:41

9M ago55:41

55:41

touchSYMPOSIUM for touchONCOLOGY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino high…

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchNEUROLOGY 33:43

9M ago33:43

33:43

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of al…

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchENDOCRINOLOGY 33:45

9M ago33:45

33:45

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management o…

1
The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy 38:58

9M ago38:58

38:58

touchIN CONVERSATION for touchONCOLOGY Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizi…

1
Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia 35:35

9M ago35:35

35:35

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients. The experts Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany Prof. Jean-Jacques Kiladjia…

1
Video 3: MDT perspectives on identifying and managing key ADC treatment toxicities in patients with metastatic breast cancer 11:54

9M ago11:54

11:54

Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, E…

1
Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer 13:03

9M ago13:03

13:03

Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory W…

1
Video 1: MDT perspectives on the safety profiles of current and emerging ADCs in metastatic breast cancer 11:59

9M ago11:59

11:59

Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA…